Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsBiotechnology Equipment

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1887614

Cover Image

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1887614

Pathology Instruments

PUBLISHED:
PAGES: 597 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Pathology Instruments Market to Reach US$6.2 Billion by 2030

The global market for Pathology Instruments estimated at US$4.5 Billion in the year 2024, is expected to reach US$6.2 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 9.3% CAGR

The Pathology Instruments market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$603.8 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Pathology Instruments Market - Key Trends & Drivers Summarized

What Are Pathology Instruments and Their Uses?

Pathology instruments are essential tools used in the diagnosis and study of diseases. These instruments include microscopes, tissue processors, slide strainers, and digital pathology systems. They are employed in clinical laboratories, research institutions, and hospitals to analyze biological samples, such as blood, tissues, and bodily fluids, to detect abnormalities and understand disease mechanisms. Pathology instruments play a crucial role in various medical fields, including oncology, hematology, and microbiology, providing critical insights that guide treatment decisions and improve patient outcomes.

How Are Technological Advancements Shaping This Market?

Technological advancements are significantly shaping the pathology instruments market. The development of digital pathology systems, which allow for the scanning, storage, and analysis of pathology slides, is revolutionizing the field. These systems enhance diagnostic accuracy, facilitate remote consultations, and enable easier sharing of data. Advances in imaging technologies, such as high-resolution and confocal microscopy, are improving the visualization of cellular structures and pathological changes. Additionally, the integration of artificial intelligence and machine learning algorithms in pathology instruments is enhancing diagnostic capabilities, enabling the automated analysis of complex data and the identification of patterns that may be missed by human eyes.

What Role Do Market Demands Play in This Industry?

Market demands are driving significant changes in the pathology instruments market. The rising prevalence of chronic diseases and cancer is increasing the need for accurate and timely diagnostics, boosting demand for advanced pathology instruments. The shift towards personalized medicine, which requires detailed molecular and genetic analysis, is also influencing the development and adoption of innovative pathology tools. The expanding geriatric population, with its higher incidence of various diseases, further fuels the need for sophisticated diagnostic instruments. Moreover, the increasing focus on early disease detection and preventive healthcare is prompting laboratories and healthcare facilities to invest in cutting-edge pathology instruments.

What Factors Are Driving Market Growth?

The growth in the pathology instruments market is driven by several factors, including the rising incidence of chronic and infectious diseases, advancements in diagnostic technologies, and increasing healthcare expenditure. The demand for precise and early diagnostic tools is propelling market growth, as early detection can significantly improve treatment outcomes. Technological innovations, such as digital pathology and AI-driven diagnostic tools, are enhancing the efficiency and accuracy of disease diagnosis. Additionally, the growing trend towards personalized medicine is driving the need for advanced pathology instruments that can provide detailed molecular and genetic insights. The expansion of healthcare infrastructure in emerging markets, along with government initiatives to improve diagnostic capabilities, is also contributing to the market's growth. These factors collectively ensure a robust demand for pathology instruments, driving the market forward.

SCOPE OF STUDY:

The report analyzes the Pathology Instruments market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

ETechnology (Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry, Other Technologies); End-Use (Diagnostics, Drug Discovery, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 114 Featured) -

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio SB
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Hamamatsu Photonics K.K
  • Mikroscan Technologies, Inc.
  • PerkinElmer Inc.
  • PHC Holdings Corporation
  • Roche Diagnostics Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP13871

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Pathology: The Silent Pillar of Modern Medicine's Evolution
    • Global Economic Update
    • Competition
    • Pathology Instruments - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic/Infectious Diseases Drives Demand for Pathology Instruments in Clinical Chemistry & Diagnostics
    • Rising Prevalence of Chronic/Infectious Diseases Drives Demand for Pathology Instruments & Devices Powering Modern Diagnostics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
    • Global Investments in Health Systems to Benefit Market Growth
    • Rise of Molecular Diagnostics to Drive a Large Chunk of Growth in the Pathology Instruments Market
    • Robust Growth of Molecular Diagnostics Services Expands the Opportunity Avenue for Pathology Instruments: Global Market for Molecular Diagnostics (In US$ Million) for Years 2023, 2025 and 2027
    • Growing Role of Pathology in Drug Development to Spur Demand for Pathology Instruments
    • From Microscope to Market, Pathology's Pivotal Role in Drug Evolution Cannot be Undermined: Global Market for Drug Discovery (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 2031
    • Rising Importance of Forensic Pathology to Spur Demand for Pathology Instruments
    • Growing Demand for Forensic Technologies & Services Translates Directly into Increased Sales of Pathology Instruments: Global Market for Forensic Technologies & Services (In US$ Million) for Years 2023, 2025, 2027 and 2029
    • Immunoassays Remain the Technology of Choice in the Field of Pathology
    • Impact of AI on Pathology Instruments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pathology Instruments Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Pathology Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Pathology Instruments by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 62: France Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 80: UK Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Pathology Instruments by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Pathology Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Pathology Instruments by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Pathology Instruments by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Pathology Instruments by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Pathology Instruments by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Pathology Instruments by Technology - Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Pathology Instruments by Technology - Percentage Breakdown of Value Sales for Molecular Diagnostics, Immunoassays Technology, Microbiology, Clinical Chemistry and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Pathology Instruments by End-Use - Diagnostics, Drug Discovery and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Pathology Instruments by End-Use - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!